• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 14, 2014

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description INOmax DSIR, model 10007, Nitric Oxide Delivery System, with Software version 3.0.0. The INOmax DS delivery system delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and a comprehensive alarm system. The primary targeted clinical setting is the Neonatal Intensive Care Unit (NICU) and secondary targeted clinical setting is the transport of neonates.
Recall Number Z-1528-2014
Classification Class II
Code Info Serial Numbers: DS20080152, DS20090218, DS20090243, DS20090271, DS20090523, DS20090598, DS20090821, DS20090925, DS20101022, DS20101076, DS20101147, DS20101374, DS20101413, DS20101420, DS20101499, DS20101637, DS20111199, DS20120099, DS20120150, DS20120169, DS20120288, DS20120306.
Product Distributed Qty 22
Reason For Recall An anomaly impacts the monitoring system of INOmax DSIR Plus (software 3.0.0). When the integrated pneumatic backup switch is activated with low or no gas flow through the injector module, an intended NO cell failure alarm will occur. In addition, an unintended NO2 cell failure alarm may also occur. The NO/NO2 cell failure alarms are caused by an average NO/NO2 circuit concentration greater than 200 ppm/25 ppm respectively over a 10 second period.

Event Detail

Event Id 67947
Product Type Devices
Status Ongoing
Recalling Firm INO Therapeutics (dba Ikaria)
City Madison
State WI
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2014-03-27
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide Distribution including DC and VA.
-
-